Results 61 to 70 of about 945,906 (220)

Mechanisms and Management of Acquired Aseptic Intracardiac Communications After Transcatheter Aortic Valve Implantation: Single‐Center Case Series Insights

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Acquired aseptic intracardiac communications (AICCs) are rare but clinically relevant structural complications following transcatheter aortic valve implantation (TAVI), typically resulting from mechanical injury to the aortic annulus, interventricular septum, or adjacent structures.
Geza Fontos, Abdelkrim Ahres, Marton Vertesaljai, Tunde Pinter, Zsolt Piroth, Matyas Pal, Peter Andreka   +6 more
wiley   +1 more source

Sustained Improvement of Left Ventricular Strain following Transcatheter Aortic Valve Replacement

, 2019
PURPOSE: Left ventricular (LV) mechanics are impaired in patients with severe aortic stenosis (AS). Transcatheter aortic valve replacement (TAVR) has become a widespread technique for patients with severe AS considered inoperable or high risk for open ...
Echeverría García, T., Habib, G., La Canna, G., Fernández-Golfín, C., Plaza Martín, M., de la Hera Galarza, J. M., López-Fernández, T., Lozano Granero, V. C., Fernández Santos, S., Faletra, F. F., Mesa, D., González Gómez, A., Zamorano Gómez, J. L., Swaans, M. J., Martínez Monzonís, Maria Amparo   +14 more
core   +1 more source

Early Experience With Evoque Transcatheter Tricuspid Valve Replacement in Carcinoid Heart Disease

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Tricuspid regurgitation (TR) is nearly universal in carcinoid heart disease (CHD), but surgical replacement carries significant risk, and CHD was excluded from the landmark TRISCEND II trial. We present seven patients with CHD undergoing Evoque transcatheter tricuspid valve replacement (TTVR) at two tertiary centers.
Jackson S. Burton, Ben Peterson, Brian Whisenant, Anwar Tandar   +3 more
wiley   +1 more source

CT in Transcatheter Aortic Valve Replacement [PDF]

Radiology, 2013
Transcatheter aortic valve replacement is a new method to treat patients with symptomatic, severe aortic stenosis who are at high surgical risk. Short- and midterm results have been encouraging, with more than 90,000 procedures performed worldwide. Patient selection, prosthesis sizing, and access strategies heavily rely on noninvasive imaging. Computed
Philipp, Blanke, U Joseph, Schoepf, Jonathon A, Leipsic   +2 more
openaire   +2 more sources

Transcatheter Aortic Valve Replacement for Aortic Stenosis With Prosthetic Mitral Paravalvular Leak and Hemolytic Anemia

JACC: Case Reports, 2020
This report describes a successful transcatheter aortic valve replacement in an older patient with severe aortic stenosis, mitral paravalvular leak, and associated hemolytic anemia.
Hideaki Kanzaki, MD, PhD, Yusuke Shimahara, MD, PhD, Makoto Amaki, MD, PhD, Atsushi Okada, MD, PhD, Tomoyuki Fujita, MD, PhD, Chisato Izumi, MD, PhD, Satoshi Yasuda, MD, PhD, Junjiro Kobayashi, MD, PhD   +7 more
doaj   +1 more source

Double Transeptal Puncture for SAPIEN M3 Transcatheter Mitral Valve Replacement: Initial Experience, Indications, and Technique

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT The SAPIEN M3 system has been recently approved for transcatheter mitral valve replacement (TMVR). The transeptal guide sheath is used to deploy the dock, which is completely released before inserting and deploying the M3 valve using the same femoral access, transeptal puncture (TSP) and guide sheath.
Clara Fernandez‐Cordon, David Hoare, Aayush Singal, Sanjeev Bhattacharyya, Suneil K. Aggarwal, Michael J. Mullen   +5 more
wiley   +1 more source

Echocardiography in Transcatheter Aortic Valve Replacement [PDF]

Heart, Lung and Circulation, 2019
Transcatheter aortic valve replacement (TAVR) is a safe and efficient alternative for surgical valve aortic replacement in patients with symptomatic severe aortic stenosis who are inoperable or have a high risk for surgery. Randomised clinical trials have shown that TAVR is not inferior to surgical aortic valve replacement in intermediate-risk patients
Vollema, E.M., Delgado, V., Bax, J.J.
openaire   +3 more sources

Outcomes of Redo Transcatheter Aortic Valve Replacement According to the Initial and Subsequent Valve Type [PDF]

, 2022
As transcatheter aortic valve (TAV) replacement is increasingly used in patients with longer life expectancy, a sizable proportion will require redo TAV replacement (TAVR). The unique configuration of balloon-expandable TAV (bTAV) vs a self-expanding TAV
Marco Russo, Konstantinos Spargias, Nicola Buzzatti, Rodés-Cabau, Josep, Federico De Marco, Hamm, Christian, Godfrey, Rebecca, Søndergaard, Lars, Niklas Schofer, Mangieri, Antonio, Ruile, Philipp, Redwood, Simon R, Bruoha, Sharon, Maarten P.H. Van Wiechen, Thiele, Holger, Sinning, Jan-Malte, Nombela-Franco, Luis, Josep Rodés-Cabau, Jules Mesnier, Antonio Colombo, Simon R. Redwood, Claudia Fiorina, De Marco, Federico, Maurovich-Horvat, Pál, Ilan Richter, Alfonso Ielasi, Kolja Sievert, Thomas Pilgrim, Franz J. Neumann, Giuseppe Tarantini, Fraccaro, Chiara, Laine, Mika, Wolfgang H. Schoels, Yoon, Sung-Han, El Sabbagh, Abdallah, Leon, Martin B., Jaffe, Ronen, Sathananthan, Janarthanan, Balint Szilveszter, Spargias, Konstantinos, Pál Maurovich-Horvat, Montorfano, Matteo, Barbanti, Marco, Abdallah El Sabbagh, Luis Nombela-Franco, Philipp Ruile, Ronen Jaffe, Sebastian Ludwig, David Hildick-Smith, Webb, John G, Tamburino, Corrado, Marco Barbanti, Sinning, Jan Malte, Tchétché, Didier, Hildick-Smith, David, Yoon, Sung Han, John G. Webb, Kullmer, Matthias, Landes, Uri, Perlman, Gidon Y., Haim Danenberg, Didier Tchétché, Finkelstein, Ariel, Lars Søndergaard, Van Wiechen, Maarten P H, Ielasi, Alfonso, Janarthanan Sathananthan, Azeem Latib, Sharon Bruoha, Okuno, Taishi, Voigtlaender, Lisa, Holger Thiele, Andreas, Martin, Amit Segev, Sievert, Kolja, Chiara Fraccaro, Ran Kornowski, Uri Landes, Makkar, Raj R., Bunc, Matjaz, Horst Sievert, Van Wiechen, Maarten P. H., Danenberg, Haim, Richter, Ilan, Makkar, Raj R, Ole De Backer, Christian Hamm, Sievert, Horst, Van Mieghem, Nicolas M., Segev, Amit, Sung-Han Yoon, Helene Eltchaninoff, Russo, Marco, Eitan, Amnon, Ariel Finkelstein, Colombo, Antonio, Kim, Won-Keun, Schofer, Niklas, Babaliaros, Vasilis C, Schoels, Wolfgang H, Amnon Eitan, Abdel-Wahab, Mohamed, Babaliaros, Vasilis C., Nicolas M. Van Mieghem, Nicolo Piazza, Kornowski, Ran, Aravadinos, Dionisis, Ludwig, Sebastian, Kim, Won Keun, Martin B. Leon, Piazza, Nicolo, Lisa Voigtlaender, Al-Kassou, Baravan, Won-Keun Kim, De Backer, Ole, Roberto Nerla, John C. Lisko, Tarantini, Giuseppe, Van Wiechen, Maarten P.H., Gidon Y. Perlman, Matjaz Bunc, Lisko, John C, Mohamed Abdel-Wahab, Israel Barbash, Leon, Martin B, Witberg, Guy, Nerla, Roberto, Neumann, Franz J., Nazif, Tamim M., Sondergaard, Lars, Matthias Kullmer, Fiorina, Claudia, Jan-Malte Sinning, Taishi Okuno, Dionisis Aravadinos, Mesnier, Jules, Lisko, John C., Rebecca Godfrey, Buzzatti, Nicola, Perlman, Gidon Y, Neumann, Franz J, Mayra Guerrero, Raj R. Makkar, Tamim M. Nazif, Latib, Azeem, Nazif, Tamim M, Redwood, Simon R., Barbash, Israel, Antonio Mangieri, Baravan Al-Kassou, Matteo Montorfano, Mika Laine, Webb, John G., Vasilis C. Babaliaros, Szilveszter, Balint, Martin Andreas, Schoels, Wolfgang H., Eltchaninoff, Helene, Corrado Tamburino, Van Mieghem, Nicolas M, Pilgrim, Thomas, Guy Witberg, Guerrero, Mayra, Bunc M., Sievert H., Nerla R., Redwood S. R., Aravadinos D., Fiorina C., Andreas M., Witberg G., Neumann, Franz-Josef, Tchetche D., Neumann F. J., Kullmer M., Finkelstein A., Tamburino C., Okuno T., Makkar R. R., Kornowski R., De Marco F., Eltchaninoff H., Segev A., Sinning J. -M., Jaffe R., Maurovich-Horvat P., Buzzatti N., Guerrero M., Nazif T. M., Al-Kassou B., Pilgrim T., Schofer N., Laine M., Thiele H., Szilveszter B., Spargias K., Leon M. B., Colombo A., Nombela-Franco L., Hamm C., Eitan A., Danenberg H., Barbash I., Ludwig S., Schoels W. H., Mangieri A., Babaliaros V. C., Voigtlaender L., Russo M., Tarantini G., De Backer O., Webb J. G., Montorfano M., Piazza N., Ielasi A., Richter I., Bruoha S., Van Wiechen M. P. H., Yoon S. -H., Kim W. -K., Ruile P., Mesnier J., Latib A., Barbanti M., Sondergaard L., Perlman G. Y., Sievert K., Hildick-Smith D., Rodes-Cabau J., El Sabbagh A., Fraccaro C., Godfrey R., Lisko J. C., Sathananthan J., Landes U., Abdel-Wahab M., Van Mieghem N. M.   +236 more
core   +1 more source

Transthyretin amyloid cardiomyopathy: Literature review and red‐flag symptom clusters for each cardiology specialty

ESC Heart Failure, Volume 12, Issue 2, Page 955-967, April 2025.
Abstract Wild‐type transthyretin amyloid cardiomyopathy (ATTRwt‐CM) is a progressive and infiltrative cardiac disorder that may cause fatal consequences if left untreated. The estimated survival time from diagnosis is approximately 3–6 years. Because of the non‐specificity of initial symptom manifestation and insufficient awareness among treating ...
Yasuhiro Izumiya, Toru Kubo, Jin Endo, Seiji Takashio, Masatoshi Minamisawa, Jun Hamada, Tomonori Ishii, Hajime Abe, Hiroaki Konishi, Kenichi Tsujita   +9 more
wiley   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source